Immunotherapy boosts standard chemo in rare abdominal cancer trial
NCT ID NCT05001880
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 10 times
Summary
This phase 2 trial is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy (carboplatin, pemetrexed, and bevacizumab) works better than chemotherapy alone for peritoneal mesothelioma, a rare cancer of the abdominal lining. About 66 people will take part. The goal is to see if the combination shrinks tumors more effectively.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Atezolizumab (immunotherapy) added to standard chemotherapy (carboplatin, pemetrexed, bevacizumab)
- What this could lead to
- If it works, this could point toward a more effective treatment for peritoneal mesothelioma, potentially improving response rates and survival.
- What could go wrong
- This is a phase 2 trial with only 66 participants, so results are preliminary. Adding immunotherapy may increase side effects without clear benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL MALIGNANT MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abbott-Northwestern Hospital
RECRUITINGMinneapolis, Minnesota, 55407, United States
-
Alliance for Clinical Trials in Oncology
RECRUITINGChicago, Illinois, 60606, United States
-
Carle Cancer Center
RECRUITINGUrbana, Illinois, 61801, United States
Contact Email: •••••@•••••
-
Carle Physician Group-Effingham
RECRUITINGEffingham, Illinois, 62401, United States
Contact Email: •••••@•••••
-
Carle Physician Group-Mattoon/Charleston
RECRUITINGMattoon, Illinois, 61938, United States
Contact Email: •••••@•••••
-
Carle at The Riverfront
RECRUITINGDanville, Illinois, 61832, United States
Contact Email: •••••@•••••
-
Fairview Southdale Hospital
RECRUITINGEdina, Minnesota, 55435, United States
-
Marshfield Medical Center - Minocqua
RECRUITINGMinocqua, Wisconsin, 54548, United States
Contact Email: •••••@•••••
-
Marshfield Medical Center - Weston
RECRUITINGWeston, Wisconsin, 54476, United States
Contact Email: •••••@•••••
-
Marshfield Medical Center-EC Cancer Center
RECRUITINGEau Claire, Wisconsin, 54701, United States
Contact Email: •••••@•••••
-
Marshfield Medical Center-Marshfield
RECRUITINGMarshfield, Wisconsin, 54449, United States
Contact Email: •••••@•••••
-
Marshfield Medical Center-Rice Lake
RECRUITINGRice Lake, Wisconsin, 54868, United States
Contact Email: •••••@•••••
-
Marshfield Medical Center-River Region at Stevens Point
RECRUITINGStevens Point, Wisconsin, 54482, United States
Contact Email: •••••@•••••
-
Mayo Clinic Hospital in Arizona
SUSPENDEDPhoenix, Arizona, 85054, United States
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
-
Mercy Hospital
RECRUITINGCoon Rapids, Minnesota, 55433, United States
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
-
Park Nicollet Clinic - Saint Louis Park
RECRUITINGSaint Louis Park, Minnesota, 55416, United States
-
Regions Hospital
RECRUITINGSaint Paul, Minnesota, 55101, United States
-
Rice Memorial Hospital
RECRUITINGWillmar, Minnesota, 56201, United States
-
Sanford Bismarck Medical Center
RECRUITINGBismarck, North Dakota, 58501, United States
Contact Email: •••••@•••••
-
Sanford Broadway Medical Center
RECRUITINGFargo, North Dakota, 58122, United States
Contact Email: •••••@•••••
-
Sanford Cancer Center Oncology Clinic
RECRUITINGSioux Falls, South Dakota, 57104, United States
Contact Email: •••••@•••••
-
Sanford Cancer Center Worthington
RECRUITINGWorthington, Minnesota, 56187, United States
-
Sanford Joe Lueken Cancer Center
RECRUITINGBemidji, Minnesota, 56601, United States
Contact Email: •••••@•••••
-
Sanford Roger Maris Cancer Center
RECRUITINGFargo, North Dakota, 58122, United States
Contact Email: •••••@•••••
-
Sanford USD Medical Center - Sioux Falls
RECRUITINGSioux Falls, South Dakota, 57117-5134, United States
Contact Email: •••••@•••••
-
The Carle Foundation Hospital
RECRUITINGUrbana, Illinois, 61801, United States
Contact Email: •••••@•••••
-
ThedaCare Regional Cancer Center
RECRUITINGAppleton, Wisconsin, 54911, United States
Contact Email: •••••@•••••
-
UPMC Hillman Cancer Center
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
-
UT MD Anderson - League City
RECRUITINGLeague City, Texas, 77573, United States
-
UT MD Anderson - Sugar Land
RECRUITINGSugar Land, Texas, 77478, United States
-
UT MD Anderson - The Woodlands
RECRUITINGConroe, Texas, 77384, United States
-
UT MD Anderson - West Houston
RECRUITINGHouston, Texas, 77079, United States
-
UT MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
United Hospital
RECRUITINGSaint Paul, Minnesota, 55102, United States
-
Unity Hospital
ACTIVE_NOT_RECRUITINGFridley, Minnesota, 55432, United States
-
University of Chicago Comprehensive Cancer Center
RECRUITINGChicago, Illinois, 60637, United States
Contact Email: •••••@•••••
-
University of Kentucky/Markey Cancer Center
ACTIVE_NOT_RECRUITINGLexington, Kentucky, 40536, United States
-
University of Oklahoma Health Sciences Center
RECRUITINGOklahoma City, Oklahoma, 73104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Abdominal chemotherapy after surgery may improve mesothelioma outcomes
- Immune booster shows promise against rare cancer
- New combo therapy targets rare abdominal cancer
- Lab-Grown tumor models could personalize mesothelioma care
- Heated chemo combo tested in abdominal cancer surgery
- New drug combo targets Hard-to-Treat cancers with genetic weakness